Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma
Mohamed A.Y. Abdel Malek(University of Cincinnati Medical Center), James J. Driscoll(University Hospitals of Cleveland)
Cited by 80
Related Papers
MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib
|Leukemia|2014|78
Pharmacogenomics and chemical library screens reveal a novel SCFSKP2 inhibitor that overcomes Bortezomib resistance in multiple myeloma
|Leukemia|2016|56
Bortezomib induces AMPK-dependent autophagosome formation uncoupled from apoptosis in drug resistant cells
|Oncotarget|2014|43